Interestingly, also in experimental animal models for multiple sclerosis, which are accompanied by an increase in oxidative–inflammatory mechanisms, these parameters were significantly reduced after treatment with drugs able to block the activity (pentamidine) or inhibit the astrocytic synthesis of S100B protein (arundic acid) [23,24]. The gene discussed is S100B; the disease is multiple sclerosis.